See up to 3 months of PCVX. The 7-day demo opens the 1M and 3M ranges and puts PCVX on your watchlist.
Start 7-day demoLatest PCVX insider trades
About Vaxcyte, Inc. (PCVX)
The SEC lists Vaxcyte, Inc. under CIK 0001649094, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
PCVX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 21 | 92,890 | $6.32M |
| Grant or award | 2 | 140,886 | |
| Option exercise | 16 | 173,896 | |
PCVX insider transactions (Form 4)
14190 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tax withholding / forfeiture | Common Stock | 1,270 | $31.56 | $40K | ||
| Tax withholding / forfeiture | Common Stock | 2,381 | $31.56 | $75K | ||
| Tax withholding / forfeiture | Common Stock | 1,429 | $31.56 | $45K | ||
| Elvia Cowan - Officer | Grant or award | Common Stock | 2,810 | $0.00 | - | |
| Elvia Cowan - Officer | Grant or award | Stock Option (right to buy) | 9,743 | $0.00 | - | |
| Anne S. Drapeau - Director | Grant or award | Common Stock | 3,041 | $0.00 | - | |
| Anne S. Drapeau - Director | Grant or award | Stock Option (right to buy) | 15,372 | $0.00 | - | |
| Option exercise | Common Stock | 4,777 | $20.93 | $100K | ||
| Option exercise | Stock Option (right to buy) | 4,777 | $0.00 | - | ||
| Option exercise | Common Stock | 15,781 | $5.35 | $84K | ||
| Option exercise | Common Stock | 4,752 | $20.93 | $99K | ||
| Option exercise | Stock Option (right to buy) | 15,781 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,752 | $0.00 | - | ||
| Option exercise | Common Stock | 8,000 | $5.35 | $43K | ||
| Open-market sale | Common Stock | 1,190 | $87.26 | $104K | ||
| Open-market sale | Common Stock | 3,373 | $88.70 | $299K | ||
| Open-market sale | Common Stock | 3,157 | $89.31 | $282K | ||
| Open-market sale | Common Stock | 280 | $90.24 | $25K | ||
| Option exercise | Stock Option (right to buy) | 8,000 | $0.00 | - | ||
| Elvia Cowan - Officer | Option exercise | Common Stock | 7,716 | $25.92 | $200K | |
| Elvia Cowan - Officer | Option exercise | Stock Option (right to buy) | 7,716 | $0.00 | - | |
| Carlos V. Paya - Director | Gift | Common Stock | 2,500 | $0.00 | - | |
| Carlos V. Paya - Director | Grant or award | Common Stock | 2,500 | $0.00 | - | |
| Carlos V. Paya - Director | Gift | Stock Option (right to buy) | 7,250 | $0.00 | - | |
| Carlos V. Paya - Director | Grant or award | Stock Option (right to buy) | 7,250 | $0.00 | - | |
| Open-market sale | Common Stock | 961 | $92.06 | $88K | ||
| Open-market sale | Common Stock | 222 | $93.10 | $21K | ||
| Open-market sale | Common Stock | 1,029 | $92.03 | $95K | ||
| Open-market sale | Common Stock | 154 | $93.60 | $14K | ||
| Mikhail Eydelman - Officer | Gift | Common Stock | 110 | $0.00 | - | |
| Mikhail Eydelman - Officer | Option exercise | Common Stock | 5,000 | $21.41 | $107K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 1,435 | $90.16 | $129K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 3,177 | $91.91 | $292K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 388 | $92.90 | $36K | |
| Mikhail Eydelman - Officer | Tax withholding / forfeiture | Common Stock | 475 | $92.06 | $44K | |
| Mikhail Eydelman - Officer | Option exercise | Stock Option (right to buy) | 5,000 | $0.00 | - | |
| Jim Wassil - Officer | Option exercise | Common Stock | 8,000 | $2.42 | $19K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 5,772 | $92.07 | $531K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,101 | $93.06 | $102K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,127 | $94.06 | $106K | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Open-market sale | Common Stock | 11,349 | $92.06 | $1.04M | ||
| Open-market sale | Common Stock | 1,409 | $93.06 | $131K | ||
| Open-market sale | Common Stock | 2,242 | $94.06 | $211K | ||
| Gift | Common Stock | 710 | $0.00 | - | ||
| Option exercise | Common Stock | 8,000 | $5.35 | $43K | ||
| Open-market sale | Common Stock | 6,111 | $85.60 | $523K | ||
| Open-market sale | Common Stock | 1,757 | $86.49 | $152K | ||
| Open-market sale | Common Stock | 132 | $87.05 | $11K | ||
| Option exercise | Stock Option (right to buy) | 8,000 | $0.00 | - | ||
| Elvia Cowan - Officer | Grant or award | Performance Stock Option (right to buy) | 11,900 | $0.00 | - | |
| Mikhail Eydelman - Officer | Grant or award | Performance Stock Option (right to buy) | 26,125 | $0.00 | - | |
| Jim Wassil - Officer | Grant or award | Performance Stock Option (right to buy) | 87,481 | $0.00 | - | |
| Jim Wassil - Officer | Grant or award | Performance Restricted Stock Units | 35,661 | $0.00 | - | |
| Open-market sale | Common Stock | 227 | $102.68 | $23K | ||
| Open-market sale | Common Stock | 463 | $103.43 | $48K | ||
| Open-market sale | Common Stock | 377 | $104.71 | $39K | ||
| Open-market sale | Common Stock | 116 | $105.50 | $12K | ||
| Open-market sale | Common Stock | 281 | $102.64 | $29K | ||
| Open-market sale | Common Stock | 363 | $103.36 | $38K | ||
| Open-market sale | Common Stock | 434 | $104.72 | $45K | ||
| Open-market sale | Common Stock | 105 | $105.50 | $11K | ||
| Option exercise | Common Stock | 663 | $0.04 | $27 | ||
| Option exercise | Common Stock | 14,129 | $2.03 | $29K | ||
| Option exercise | Common Stock | 16,000 | $5.35 | $86K | ||
| Option exercise | Stock Option (right to buy) | 663 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 14,129 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 16,000 | $0.00 | - | ||
| Grant or award | Performance Stock Option (right to buy) | 197,784 | $0.00 | - | ||
| Grant or award | Performance Restricted Stock Units | 80,625 | $0.00 | - | ||
| Grant or award | Performance Stock Option (right to buy) | 87,481 | $0.00 | - | ||
| Grant or award | Performance Restricted Stock Units | 35,661 | $0.00 | - | ||
| Mikhail Eydelman - Officer | Option exercise | Common Stock | 5,000 | $21.41 | $107K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 788 | $104.80 | $83K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 1,415 | $105.72 | $150K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 1,524 | $106.82 | $163K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 1,273 | $107.50 | $137K | |
| Mikhail Eydelman - Officer | Option exercise | Stock Option (right to buy) | 5,000 | $0.00 | - | |
| Jim Wassil - Officer | Option exercise | Common Stock | 8,000 | $2.42 | $19K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 4,955 | $106.34 | $527K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 2,174 | $107.20 | $233K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 631 | $108.25 | $68K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 240 | $108.93 | $26K | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Open-market sale | Common Stock | 9,955 | $106.35 | $1.06M | ||
| Open-market sale | Common Stock | 3,312 | $107.34 | $356K | ||
| Open-market sale | Common Stock | 1,733 | $108.50 | $188K | ||
| Jim Wassil - Officer | Option exercise | Common Stock | 1,585 | $5.35 | $8K | |
| Jim Wassil - Officer | Option exercise | Common Stock | 3,464 | $20.93 | $73K | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 1,585 | $0.00 | - | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 3,464 | $0.00 | - | |
| Option exercise | Common Stock | 19,108 | $20.93 | $400K | ||
| Option exercise | Stock Option (right to buy) | 19,108 | $0.00 | - | ||
| Option exercise | Common Stock | 8,000 | $5.35 | $43K | ||
| Option exercise | Common Stock | 8,000 | $5.35 | $43K | ||
| Option exercise | Common Stock | 12,000 | $5.35 | $64K | ||
| Option exercise | Common Stock | 14,000 | $5.35 | $75K | ||
| Open-market sale | Common Stock | 36,114 | $115.26 | $4.16M | ||
| Open-market sale | Common Stock | 5,886 | $116.19 | $684K | ||
| Option exercise | Stock Option (right to buy) | 8,000 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 8,000 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 12,000 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 14,000 | $0.00 | - | ||
| Mikhail Eydelman - Officer | Option exercise | Common Stock | 5,000 | $21.41 | $107K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 476 | $107.51 | $51K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 996 | $108.69 | $108K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 3,147 | $109.55 | $345K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 314 | $110.51 | $35K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 67 | $111.68 | $7K | |
| Mikhail Eydelman - Officer | Option exercise | Stock Option (right to buy) | 5,000 | $0.00 | - | |
| Open-market sale | Common Stock | 310 | $107.27 | $33K | ||
| Open-market sale | Common Stock | 887 | $108.72 | $96K | ||
| Open-market sale | Common Stock | 2,113 | $109.58 | $232K | ||
| Open-market sale | Common Stock | 239 | $110.35 | $26K | ||
| Open-market sale | Common Stock | 356 | $107.50 | $38K | ||
| Open-market sale | Common Stock | 807 | $108.75 | $88K | ||
| Open-market sale | Common Stock | 1,849 | $109.43 | $202K | ||
| Open-market sale | Common Stock | 537 | $110.20 | $59K | ||
| Jim Wassil - Officer | Option exercise | Common Stock | 8,000 | $2.42 | $19K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 2,312 | $113.42 | $262K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 3,349 | $114.32 | $383K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 2,339 | $114.95 | $269K | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Mikhail Eydelman - Officer | Option exercise | Common Stock | 5,500 | $21.41 | $118K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 1,414 | $113.38 | $160K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 3,056 | $114.37 | $350K | |
| Mikhail Eydelman - Officer | Open-market sale | Common Stock | 1,030 | $115.01 | $118K | |
| Mikhail Eydelman - Officer | Option exercise | Stock Option (right to buy) | 5,500 | $0.00 | - | |
| Open-market sale | Common Stock | 3,624 | $113.38 | $411K | ||
| Open-market sale | Common Stock | 7,088 | $114.27 | $810K | ||
| Open-market sale | Common Stock | 4,288 | $114.99 | $493K | ||
| Option exercise | Common Stock | 20,000 | $5.35 | $107K | ||
| Open-market sale | Common Stock | 4,305 | $113.35 | $488K | ||
| Open-market sale | Common Stock | 9,429 | $114.20 | $1.08M | ||
| Open-market sale | Common Stock | 6,266 | $114.93 | $720K | ||
| Option exercise | Common Stock | 20,000 | $5.35 | $107K | ||
| Open-market sale | Common Stock | 4,899 | $113.37 | $555K | ||
| Open-market sale | Common Stock | 9,627 | $114.28 | $1.10M | ||
| Open-market sale | Common Stock | 5,474 | $114.98 | $629K | ||
| Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - |
Recent PCVX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Cowan Elvia | Officer | 19,000 | $1.65M | View on EDGAR | |
| Wassil Jim | Officer | 18,000 |
Stock trades in PCVX disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Purchase |
PCVX insider trading FAQ
What is the latest insider trade for PCVX?
Vaxcyte, Inc. (PCVX) had 18 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for PCVX runs to 90 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PCVX stock?
No insider purchases of PCVX were filed in the last 90 days.
How many insiders are selling PCVX stock?
21 insider sales of PCVX were filed in the last 90 days, totaling $6.32M.
Where can I see PCVX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PCVX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jim Wassil view on EDGAR
- - Elvia Cowan view on EDGAR
- - Jim Wassil view on EDGAR
- - Grant Pickering view on EDGAR
- - Andrew Guggenhime view on EDGAR
- - Harpreet S. Dhaliwal view on EDGAR
- - Elvia Cowan view on EDGAR
- - Jim Wassil view on EDGAR
- - Luis Jodar view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PCVX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PCVX with a 7-day demo
- PCVX on your watchlist
- Every PCVX Form 4 filing on record
- Up to 3 months of PCVX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive